文献速递甲状腺与颈部外科

经口腔前庭入路腔镜甲状腺手术治疗最大径>2 cm甲状腺乳头状癌的临床研究

[A clinical study of transoral endoscopic thyroidectomy vestibular approach for papillary thyroid carcinoma with tumor diameter >2 cm].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2026-01-01

本研究为回顾性病例系列研究,纳入60例接受经口腔前庭入路腔镜甲状腺手术(TOETVA)的甲状腺乳头状癌患者,原发灶最大径M(IQR)为25.6(9.2)mm(范围21~46 mm)。60例手术均在腔镜下完成,无中转开放,初步效果满意,提示TOETVA用于最大径>2 cm的PTC可行。

要点

  • TOETVA治疗最大径>2 cm的甲状腺乳头状癌可行,60例均腔镜下完成,无中转开放。
  • 术后2例暂时性甲状旁腺功能减退、2例暂时性声音嘶哑,均恢复。
  • 随访1例术后1年发现颈侧区淋巴结转移并手术,余未见肿瘤残留或复发。

核心结论

  • TOETVA治疗肿瘤最大径>2 cm的甲状腺乳头状癌是可行的,初步效果满意。

研究设计与样本

  • 本研究为回顾性病例系列研究,收集2025年1—12月三家医院行TOETVA的60例甲状腺乳头状癌患者临床资料。
  • 60例中男性11例(18.3%)、女性49例(81.7%),年龄(30.2±9.0)岁(范围8~59岁)。
  • 10例接受双侧甲状腺腺叶切除+双侧中央区淋巴结清扫,50例接受单侧甲状腺腺叶切除+同侧中央区淋巴结清扫。

主要发现

  • 60例手术均在腔镜下顺利完成,无中转开放;术后病理均为甲状腺乳头状癌,单侧癌50例、双侧癌10例。
  • 原发灶最大径M(IQR)为25.6(9.2)mm(范围21~46 mm);术中发现4例侵犯喉返神经、5例侵犯肌肉、1例侵犯食管。
  • 手术时间(94.1±16.4)min(范围55~125 min),术后住院时间6(2)d(范围4~10 d)。
  • 清扫中央区淋巴结14(6)枚(范围2~37枚),阳性淋巴结3(5)枚(范围0~32枚),中央区淋巴结转移率(41.5±29.1)%(范围0~100%)。
  • 随访中1例术后1年复查发现颈侧区淋巴结转移并行颈侧区淋巴结清扫术,余病例未见肿瘤残留或复发。

临床怎么用

  • 对最大径>2 cm的甲状腺乳头状癌,TOETVA可作为经选择的可行术式,需注意喉返神经、肌肉及食管侵犯的术中评估。
  • 术后需监测血钙和甲状旁腺素,本组暂时性甲状旁腺功能减退者术后1个月复查恢复正常。
  • 术后应规律随访颈侧区淋巴结,本组1例术后1年发现颈侧区转移并接受清扫。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the feasibility of the transoral endoscopic thyroidectomy vestibular approach (TOETVA) for papillary thyroid carcinoma (PTC) with a tumor diameter>2 cm. Methods: This is a retrospective case series study. Clinical data of 60 patients with PTC who underwent TOETVA were collected from the Department of Thyroid Surgery of the First Affiliated Hospital of Zhengzhou University,the Department of General Surgery of Haicang Hospital Affiliated to Xiamen Medical College,and the Department of General Surgery of Zhongshan Hospital Affiliated to Xiamen University between January and December 2025. The study comprised 11 males (18.3%) and 49 females (81.7%),with an age of (30.2±9.0) years (range:8 to 59 years). Among them, 10 cases underwent bilateral thyroid lobectomy with bilateral central zone lymph node dissection, while 50 cases underwent unilateral thyroid lobectomy with ipsilateral central zone lymph node dissection. Postoperative follow-up was conducted via outpatient visits and telephone calls, with the cutoff date set at March 31,2026. Results: All 60 procedures were successfully completed under endoscopy,with no conversion to open surgery. Postoperative pathological examination confirmed PTC in all patients,including 50 cases of unilateral carcinoma and 10 cases of bilateral carcinoma. The maximum diameter (M(IQR) of the primary lesion was 25.6 (9.2) mm (range: 21 to 46 mm). Intraoperatively,recurrent laryngeal nerve invasion was observed in 4 cases,muscle invasion in 5 cases,and esophageal invasion in 1 case. The mean operative time was (94.1±16.4) min (range: 55 to 125 min). The postoperative serum calcium level was (2.17±0.17) mmol/L (range: 1.79 to 2.62 mmol/L),and the parathyroid hormone (PTH) level was 31.85 (13.46) pg/ml (range: 6.3 to 70.8 pg/ml). The drainage volume on the first postoperative day was 70.0 (55.0) ml (range: 4 to 130 ml), and the duration of drainage was 3 (1) d (range: 2 to 5 d). The number of harvested central compartment lymph nodes was 14 (6) (range: 2 to 37),with 3 (5) positive nodes (range: 0 to 32 positive nodes); the central compartment lymph node metastasis rate was (41.5±29.1)% (range:0 to 100%). The postoperative hospital stay was 6 (2) d (range: 4 to 10 d). No complications such as lymphatic leakage,choking on drinking water,or postoperative hemorrhage occurred. Two patients developed transient hypoparathyroidism,and their PTH levels normalized at the 1-month postoperative follow-up. Two patients experienced transient hoarseness,all of whom recovered within 6 months after surgery. During follow-up,1 patient was diagnosed with lateral cervical lymph node metastasis at 1-year postoperative re-examination and underwent lateral cervical lymph node dissection; no tumor residue or recurrence was detected in the remaining cases. Conclusion: Transoral endoscopic thyroidectomy via the vestibular approach is feasible for PTC with a maximum tumor diameter>2 cm, and yields satisfactory preliminary outcomes. 目的: 探讨经口腔前庭入路腔镜甲状腺手术(TOETVA)治疗最大径>2 cm的甲状腺乳头状癌的可行性及效果。 方法: 本研究为回顾性病例系列研究。收集2025年1—12月郑州大学第一附属医院甲状腺外二科、厦门医学院附属海沧医院普通外科、厦门大学附属中山医院普通外科收治的行TOETVA的60例甲状腺乳头状癌患者的临床资料。男性11例(18.3%),女性49例(81.7%);年龄(30.2±9.0)岁(范围:8~59岁)。其中10例接受双侧甲状腺腺叶切除+双侧中央区淋巴结清扫,50例接受单侧甲状腺腺叶切除+同侧中央区淋巴结清扫。术后通过门诊及电话对患者进行随访,随访截至2026年3月31日。 结果: 60例手术均在腔镜下顺利完成,无中转开放。术后病理学检查结果均为甲状腺乳头状癌,其中单侧癌50例,双侧癌10例,原发灶最大径[M(IQR)]为25.6(9.2)mm(范围:21~46 mm)。术中发现4例侵犯喉返神经,5例侵犯肌肉,1例侵犯食管。手术时间为(94.1±16.4)min(范围:55~125 min),术后血钙浓度为(2.17±0.17)mmol/L(范围:1.79~2.62 mmol/L),甲状旁腺素为31.85(13.46)pg/ml(范围:6.3~70.8 pg/ml);术后第1天引流量为70.0(55.0)ml(范围:4~130 ml),拔管时间为3(1)d(范围:2~5 d);清扫中央区淋巴结14(6)枚(范围:2~37枚),阳性淋巴结数目为3(5)枚(范围:0~32枚),中央区淋巴结转移率为(41.5±29.1)%(范围:0~100%);术后住院时间为6(2)d(范围:4~10 d)。患者术后均未发生淋巴漏、饮水呛咳及出血等并发症,2例发生暂时性甲状旁腺功能减退,术后1个月门诊复查甲状旁腺素恢复正常,2例发生暂时性声音嘶哑,均于术后6个月内恢复正常。随访过程中,1例患者术后1年复查发现颈侧区淋巴结转移,行颈侧区淋巴结清扫术,余病例未见肿瘤残留或复发。 结论: TOETVA治疗肿瘤最大径>2 cm的甲状腺乳头状癌是可行的,初步效果满意。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang YY, Lai FY, Li LW, et al. [A clinical study of transoral endoscopic thyroidectomy vestibular approach for papillary thyroid carcinoma with tumor diameter >2 cm]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 42509219. doi:10.3760/cma.j.cn112139-20260505-00177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。